This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive  Media Kit

Home   About   Scholarships   Meetings   Publications   Resources   Feb. 5, 2013

 



Study recommends new tools to improve global mapping
of infectious disease

National Institute for Mathematical and Biological Synthesis via Medical Xpress
Since the mid-19th century, maps have helped elucidate the deadly mysteries of diseases like cholera and yellow fever. Yet today's global mapping of infectious diseases is considerably unreliable and may do little to inform the control of potential outbreaks, according to a new systematic mapping review of all clinically important infectious diseases known to humans.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
read more


PRODUCT SHOWCASE
  We've got you covered
Dealing with infectious samples is risky enough.
Why increase your risk by overlooking transport regulations?

Saf-T-Pak provides the solutions required for 49 CFR compliance:
 


Health officials deal with growing AIDS epidemic in Latino community
Fox News Latino
A rise in AIDS cases in New York City's immigrant community has prompted city officials to call it a "public health failure." But New York, which saw a 4 percent rise in AIDS cases among foreign-born Latinos in three years, to 31 percent, is not alone in dealing with a growing crisis in the Latino community — and health officials are scrambling to figure how to solve the problem.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
read more


WCRF: 13,000 cancer deaths 'can be prevented'
BBC
At least 13,000 premature deaths from cancer could be prevented each year in the U.K., says the World Cancer Research Fund. It says the government could do more to raise awareness of how people can reduce their cancer risk.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
read more


CellaVision Automates and Standardizes the Manual Differential


CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Triturus - True Open Flexibility

As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

1-800-379-0957. diaginfo@grifols.com
Trust in Cleveland Clinic Laboratories

Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.


Researchers: Vitamin D holds promise in battling a deadly breast cancer
HealthCanal.com
In research published in The Journal of Cell Biology, a team led by Dr. Susana Gonzalo, assistant professor of biochemistry and molecular biology at Saint Louis University, has discovered a molecular pathway that contributes to triple-negative breast cancer. In addition, Gonzalo and her team identified vitamin D and some protease inhibitors as possible new therapies and discovered a set of three biomarkers that can help to identify patients who could benefit from the treatment.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
read more


Computer-assisted diagnostics systems may help improve utilization
of clinical pathology laboratory tests

Dark Daily
Computer diagnostics could offer opportunity for pathologists and clinical laboratory managers to add value to clinicians in diagnosing diseases Efforts are intensifying to develop computer software that successfully emulates the skills of highly proficient diagnosticians. The motivation is increased pressure to reduce medical errors, including misdiagnosis.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
read more




Tuberculosis vaccine hopes dashed
BBC
A major trial of a new booster vaccine has ended in failure, marking a major setback in the fight against tuberculosis. It was the first major trial of a TB vaccine since Bacillus Calmette-Guerin was introduced in 1921. The trial, in South Africa, involved 2,794 healthy children aged four to six months, half of whom received MVA85A and the rest a placebo.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
read more


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Scientists seek out cancer cells hiding from treatment (Imperial College London)
CDC: Salmonella cause of most foodborne-illness outbreaks (HealthDay News via U.S. News & World Report)
In breast cancer metastasis, researchers identify possible drug target (ScienceDaily)
Folic acid unlikely to increase risk of cancer (Medical News Today)
Putting the squeeze on cells (MIT via Science Codex)

Don't be left behind. Click here to see what else you missed.


Consumer Reports tackles cancer screening tests
ABC News
For the first time ever, consumers can get ratings of cancer screening tests the same way they do for their toaster. Of the 11 common screenings evaluated by Consumer Reports, only three were recommended — and even then, only for certain age groups. Specifically, Consumer Reports gave its most positive ratings for cervical cancer screening in women age 21 to 65 and colon cancer screening in people age 50 to 75.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
read more


POWERVAR - Reliable Power Since 1986
POWERVAR offers an in-depth product portfolio of real solutions and real protection for the technology your business relies on to keep your operation running smoothly. MORE
Advertise here!

To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, Contact James DeBois at 469-420-2618.
MORE


Bird flu research resumes — but not in US
CNN
Drama surrounding research on the deadly H5N1 avian flu continues, as 40 scientists urge work on the virus to continue in countries that have established guidelines on the safety and aims of the research. The United States is not among them. This new correspondence, a letter from researchers published recently in the journals Science and Nature, comes after a "voluntary pause" in the research, which scientists announced in January 2012.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
read more


Spread of hepatitis C pinpointed
BBC
Scientists say they have, for the first time, worked out the pattern of spread of hepatitis C, showing early diagnosis is key to preventing epidemics. A study in injecting drug users in Greece indicated that each infected person spread the disease to 20 others — 10 of these in the first two years.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
read more


Tuberculosis early diagnosis improved by assay
Medscape Medical News
A Cochrane Review shows that the rapid, automated Xpert MTB/RIF assay is a sensitive and specific test for tuberculosis. It is effective when used as an initial diagnostic test for TB as well as for rifampicin-resistant TB.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
read more




Cancer researchers find progress in glowing mice
The Daily Tar Heel
University of North Carolina researchers are continuing to seek innovative ways to fight cancer — this time, with glow-in-the-dark mice. Professor of Medicine Dr. Norman Sharpless' latest experiment involved genetically engineering mice to measure an organic response to aging and cancerous cells.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
read more


DIY bioprinter lets wannabe scientists build structures from living cells
Wired
A new bioprinter developed at a hackerspace can print living cells for less than the cost of an iPod touch. The 3-D bioprinters have the potential to change the way medical research is conducted, even print living tissue and replacement organs, but they are expensive and highly specialized. They literally build living structures, like blood vessels or skin tissue, cell by cell, revolutionizing biomedical engineering.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
read more


Hops, key to flavor in beer, may prove useful in new drugs
University of Washington via HealthDay
Age-old wisdom has suggested that a bit of beer might be good for you. Now, new information suggests that the bitter compounds in beer might aid in the development of new drugs for diabetes, some types of cancer and other health problems.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
read more
 



ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news


This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Join ASCLS and we will subscribe you -- it's free!

Recent issues

Jan 30, 2013
Jan. 29, 2013
Jan. 22, 2013
Jan. 15, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063